Concerning ovarian carcinoma cells, TRPV6, TRPC3 and T-type calcium channel are found to be overexpressed leading to think that these proteins could be considered as therapeutic targets [13, 46, 47]. This evidence concerns the gene TRPC3 and ovarian carcinoma.